BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 27101016)

  • 21. Multidrug resistance related proteins in primary cutaneous lymphomas.
    van Haselen CW; Flens MJ; Scheper RJ; van der Valk P; Scheffer GL; Toonstra J; van Vloten WA
    Adv Exp Med Biol; 1999; 457():119-31. PubMed ID: 10500787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early detection of cutaneous lymphoma.
    Abd-el-Baki J; Stefanato CM; Koh HK; Demierre MF; Foss FM
    Oncology (Williston Park); 1998 Oct; 12(10):1521-30; discussion 1532-4. PubMed ID: 9798206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cutaneous B-cell lymphoma with histologic features of mycosis fungoides.
    Chiang S; DiCaudo DJ; Valdez R; Swanson DL
    J Am Acad Dermatol; 2010 Feb; 62(2):320-3. PubMed ID: 19811849
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Follicular mycosis fungoides (FMF): a rare disease].
    Zipprich F; Bräuninger W; Knop J; Enk A
    Hautarzt; 2001 Mar; 52(3):240-3. PubMed ID: 11284071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
    Willemze R; Hodak E; Zinzani PL; Specht L; Ladetto M;
    Ann Oncol; 2013 Oct; 24 Suppl 6():vi149-54. PubMed ID: 23868906
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnosis and treatment for cutaneous T-cell lymphomas].
    Hamada T; Iwatsuki K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():537-43. PubMed ID: 23134012
    [No Abstract]   [Full Text] [Related]  

  • 27. Erythema gyratum repens-like eruption in mycosis fungoides: is dermatophyte superinfection underdiagnosed in cutaneous T-cell lymphomas?
    Jouary T; Lalanne N; Stanislas S; Vergier B; Delaunay M; Taieb A
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(10):1276-8. PubMed ID: 18331299
    [No Abstract]   [Full Text] [Related]  

  • 28. Intraocular T-cell lymphoma due to mycosis fungoides and response to intravitreal methotrexate.
    Reddy R; Kim SJ
    Ocul Immunol Inflamm; 2011 Aug; 19(4):234-6. PubMed ID: 21770799
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of advanced mycosis fungoides with comprehensive skin and visceral organs metastasis: sensitive to chemical and biological therapy.
    Liu YQ; Zhu WY; Shu YQ; Gu YH
    Asian Pac J Trop Med; 2012 Aug; 5(8):669-72. PubMed ID: 22840460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management of cutaneous B-cell lymphoma: recommendations of the French cutaneous lymphoma study group].
    Grange F; D'Incan M; Ortonne N; Dalac S; Laroche L; Beylot-Barry M; Delfau-Larue MH; Vergier B; Bagot M;
    Ann Dermatol Venereol; 2010; 137(8-9):523-31. PubMed ID: 20804896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [New national treatment guidelines for primary cutaneous lymphoma].
    Belfrage E; Relander T; Brauner H
    Lakartidningen; 2021 Aug; 118():. PubMed ID: 34498247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous lymphomas: the analysis of cases treated in the Department of Dermatology University Hospital in Krakow.
    Spałkowska M; Brzewski P; Walter S; Jaworek AK; Sułowicz J; Andres M; Wojas-Pelc A
    Przegl Lek; 2016; 73(7):452-9. PubMed ID: 29676886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical imiquimod as treatment for different kinds of cutaneous lymphoma.
    Coors EA; Schuler G; Von Den Driesch P
    Eur J Dermatol; 2006; 16(4):391-3. PubMed ID: 16935796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary cutaneous lymphomas other than mycosis fungoides.
    Gilliam AC; Wood GS
    Semin Oncol; 1999 Jun; 26(3):290-306. PubMed ID: 10375086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FoxP3-positive T cell lymphoma arising in non-HTLV1 carrier: clinicopathological analysis of 11 cases of PTCL-NOS and 2 cases of mycosis fungoides.
    Satou A; Asano N; Kato S; Katsuya H; Ishitsuka K; Elsayed AA; Nakamura S
    Histopathology; 2016 Jun; 68(7):1099-108. PubMed ID: 26426838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival data for 299 patients with primary cutaneous lymphomas: a monocentre study.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    Acta Derm Venereol; 2011 Sep; 91(5):521-5. PubMed ID: 21547335
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Skin-Directed Therapies in Cutaneous T-Cell Lymphoma.
    Nguyen CV; Bohjanen KA
    Dermatol Clin; 2015 Oct; 33(4):683-96. PubMed ID: 26433841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modern radiation therapy for primary cutaneous lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group.
    Specht L; Dabaja B; Illidge T; Wilson LD; Hoppe RT;
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):32-9. PubMed ID: 25863751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
    Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
    J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cutaneous lymphoma].
    Beyeler M; Burg G; Dummer R
    Hautarzt; 2004 Oct; 55(10):1005-16; quiz 1017. PubMed ID: 15349694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.